MINERALYS THERAPEUTICS, INC. (MLYS)

(10% Negative) MINERALYS THERAPEUTICS, INC. (MLYS) Announces Delay in Adults Trials for Hypertension Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

COHERENT CORP. (COHR)

📋 STEPHEN SKAGGS (Director) plans to sell 4K shares of COHERENT CORP. (at $235.72 each, total $830K) Filed: Mar 09, 2026 | ID: 002371